[1]
“Evaluate the benefit effects of Dodonaea viscosa in kidney of infected rats with Staphylococcus aureus”, Journal of Pharmaceutical Negative Results, vol. 13, no. 3, pp. 291–294, Sep. 2022, doi: 10.47750/pnr.2022.13.03.046.